FDA clears Cutera's device for fungal nail infections

04/7/2011 | Reuters

Cutera has FDA clearance to market its GenesisPlus laser for treating fungal nail infections. Cutera CEO Kevin Connors said many patients "are dissatisfied with the current treatment options, including topical therapies and oral medications."

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Catheter Engineer Manager
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Senior Manager, Compliance
Stryker
Fremont, CA
Director, Office of Device Evaluation
FDA, Center for Devices and Radiological Health
Silver Spring, MD
Director, Office of Compliance
FDA, Center for Devices and Radiological Health
Silver Spring, MD